19240-26-7

Upstream product

• 3956-78-3 CbzGly-L-PheOEt 
• 17519-47-0 ethyl (tert-butoxycarbonyl)glycyl-L-phenylalaninate 
• 7524-50-7 methyl (2S)-2-amino-3-phenylpropanoate hydrochloride 
• 3081-24-1 H-Phe-OEt 
• 3182-93-2 (L)-phenylalanine ethyl ester hydrochloride 

Downstream Products

• 72732-47-9 Tyr-D-Met(O)-Gly-Phe-NH-NH₂ 
• 74085-65-7 (S)-2-[2-((R)-2-Amino-4-methanesulfinyl-butyrylamino)-acetylamino]-3-phenyl-propionic acid ethyl ester 
• 74085-64-6 (S)-2-[2-((R)-2-tert-Butoxycarbonylamino-4-methanesulfinyl-butyrylamino)-acetylamino]-3-phenyl-propionic acid ethyl ester 
• 74085-70-4 (R)-2-[(S)-2-Amino-3-(4-hydroxy-phenyl)-propionylamino]-N-{[(S)-1-benzyl-2-(N'-butyryl-hydrazino)-2-oxo-ethylcarbamoyl]-methyl}-4-methanesulfinyl-butyramide 
• 74085-78-2 (R)-2-[(S)-2-Amino-3-(4-hydroxy-phenyl)-propionylamino]-N-{[(S)-1-benzyl-2-(N'-hexanoyl-hydrazino)-2-oxo-ethylcarbamoyl]-methyl}-4-methanesulfinyl-butyramide 
• 74085-68-0 Z-Tyr-D-Met(O)-Gly-Phe-NHNH₃ 
• 74085-67-9 Z-Tyr-D-Met(O)-Gly-Phe-OEt 
• 74085-69-1 [(S)-1-[(R)-1-({[(S)-1-Benzyl-2-(N'-butyryl-hydrazino)-2-oxo-ethylcarbamoyl]-methyl}-carbamoyl)-3-methanesulfinyl-propylcarbamoyl]-2-(4-hydroxy-phenyl)-ethyl]-carbamic acid benzyl ester 
• 74085-77-1 [(S)-1-[(R)-1-({[(S)-1-Benzyl-2-(N'-hexanoyl-hydrazino)-2-oxo-ethylcarbamoyl]-methyl}-carbamoyl)-3-methanesulfinyl-propylcarbamoyl]-2-(4-hydroxy-phenyl)-ethyl]-carbamic acid benzyl ester 
• 80384-21-0 (S)-2-[2-((R)-2-tert-Butoxycarbonylamino-4-methylsulfanyl-butyrylamino)-acetylamino]-3-phenyl-propionic acid ethyl ester 

Relevant academic research and scientific papers

Development of novel enkephalin analogues that have enhanced opioid activities at both μ and δ opioid receptors

Enkephalin analogues with a 4-anilidopiperidine scaffold have been designed and synthesized to achieve therapeutic benefit for the treatment of pain due to mixed μ and δ opioid agonist activities. Ligand 16, in which a Dmt-substituted enkephalin-like stru

Dehydrooligopeptides. IV. Synthesis of Various Types of Dehydrodi- and tripeptides by Fragment Condensation and Base-Catalyzed β-Elimination

The synthesis of dehydrotripeptides, composed of an α-amino acid and two α-dehydroamino acid (DHA) residues, by the direct coupling of N-protected δ1-dehydrotripeptide with DHA ester and by the β-elimination od δ1-dehydrodipeptide co